All news

Two Genmab (GMAB) directors sell shares at DKK 3,540.87 per share.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Two Genmab A/S (GMAB) directors, Martin Schultz and Mijke Zachariasse, sold shares on November 12, 2026. Schultz sold 617 shares and Zachariasse sold 351 shares, with each transaction priced at DKK 3,540.87. These transactions were disclosed in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse.

Read original source

GMAB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.